The FDA is fast-tracking efforts to produce an over-the-counter version of naloxone, a life-saving drug which can reverse an opioid overdose. Current FDA-approved versions of naloxone require a prescription, creating a barrier of use for some.
CVS Health and Walmart have reached a new, multiyear deal to continue their pharmacy business…
It was a record-breaking year for global venture capital (VC) funding in digital health, with more…
CMS’ Center for Medicare and Medicaid Innovation (CMMI) has announced a new model that aims to…
The Trump administration’s CMS has proposed a number of changes to the 2020 coverage year,…
Walgreens Boots Alliance (WBA) has teamed up with technology company Microsoft to develop new…
Two new lawsuits have been filed against Baylor St. Luke’s Medical Center, the fourth and fifth…